The right medication for you depends on your individual weight loss goals, medical history, and lifestyle
The rate of nausea in the latest trial for high-dose patients was 36.4%, while 23.1% experienced vomiting, compared with 8.4% and 3.8%, respectively, for the placebo group
Abenhaim HA, Kinch RA, Morin L, Benjamin A, Usher R: Effect of prepregnancy body mass index categories on obstetrical and neonatal outcomes
GIP/GLP-1 RAs GIP/GLP-1 RAs have a dual hormonal activation that promotes satiety, slows digestion, and reduces hunger
4m and Extended Data Fig
If you want another overview of GLP-1 treatment options, our article on how to get a GLP-1 medication for weight loss is a helpful next step